Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
46.35498
male
0
5
Lung Cancer
Cancer
2
12
under $11k
0
5,674
3,828.9844
4,581.27734
28
white
20.898438
18
0.672974
0.373962
1
0
0
metastatic
0.9
0.9
no dnr
5
65
12.199219
114
42
36.09375
314.25
4.299805
0.899902
2.199707
132
7.419922
315
46
80
0
0
no(M2 and SIP pres)
0
260
1
70.97894
male
0
8
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
8,574
6,221.0352
6,140.19922
14
white
12.798828
20
0.886963
0.810913
1
0
0
yes
0.9
0.8
no dnr
8
56
12.099609
65
30
34.09375
48
1.399902
1
1.5
148
7.329102
259
15
855
2
null
null
1.838867
746
0
68.91199
male
0
4
CHF
COPD/CHF/Cirrhosis
2
9
under $11k
0
3,216
2,273.0098
2,179.63867
9
white
21.199219
15
0.835938
0.730957
1
0
0
no
0.5
0.5
no dnr
4
103
8
122
24
35.19531
null
2
0.5
0.5
132
null
345
7
4,215
0
0
SIP>=30
0
746
0
85.26495
female
0
8
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
89
9,667
6,643.6367
6,619.07812
16
black
16.097656
23
0.550903
0.437988
1
0
1
no
0.3
0.2
dnr after sadm
1
105
4.5
61
24
36.69531
252.375
2.899902
0.799927
2.299805
140
7.389648
85
48
2,200
null
6
adl>=4 (>=5 if sur)
6
517
1
45.02698
female
0
48
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
under $11k
44
58,833
40,751.25
44,380.3438
30.25
white
25.5
62
0.733887
0.651978
1
0
0
no
0
0
dnr after sadm
11
61
5.699219
48
24
36.19531
319
4
0.699951
1.399902
142
7.379883
179
18
null
null
3
adl>=4 (>=5 if sur)
3
743
0
48.33698
female
0
63
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
>$50k
0
124,981
83,853.9375
93,904.375
43.75
white
28.597656
39
0.783936
0.713989
2
1
0
no
1
1
no dnr
63
130
14.398438
73
30
38.39844
372
null
null
0.899902
140
7.419922
155
39
2,475
null
6
adl>=4 (>=5 if sur)
6
164
1
38.58499
male
0
11
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
34,372
22,292.2031
24,260.3594
26.5
white
19.296875
37
0.890991
0.851929
9
0
0
no
0.8
0.7
no dnr
11
53
13.599609
136
44
36.59375
127.5
3.599609
1
2.299805
135
7.439453
226
46
2,537
null
0
no(M2 and SIP pres)
0
728
0
30.754
male
0
6
MOSF w/Malig
ARF/MOSF
1
10
under $11k
9
7,459
4,904.0312
6,021.66797
9
white
31.199219
50
0.459961
0.339966
1
0
0
metastatic
0.1
0
dnr after sadm
4
107
13.5
64
20
36.19531
144.4375
2.099609
2.199707
0.5
131
7.529297
158
8
3,600
0
5
<2 mo. follow-up
5
7
1
34.93997
male
1
3
Coma
Coma
0
12
null
100
45,217
29,206.0625
32,382.0781
38
black
22.898438
41
0.441956
0.367981
10
0
0
no
null
null
no dnr
3
118
7
60
33
35.79688
134.6875
2.599609
13
0.599976
136
7.479492
180
15
1,305
null
null
<2 mo. follow-up
2.626953
3
1
70.62598
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
13,183
8,607.6953
9,377.92969
16.5
black
23.898438
30
0.762939
0.687988
3
0
1
no
0.8
0.75
no dnr
7
63
27.398438
96
22
36
157.5
2.199707
0.599976
1.799805
123
7.489258
307
7
3,480
0
1
no(M2 and SIP pres)
1
726
0
57.84299
female
1
5
Coma
Coma
1
12
>$50k
94
27,572
17,283.375
20,537.25
40
white
29.898438
31
0.097992
0.057999
5
0
0
no
1
0.5
no dnr
5
68
13.599609
69
28
39.89844
506.625
null
null
0.899902
137
7.439453
161
12
2,660
null
0
<2 mo. follow-up
0
5
1
78.60394
male
0
9
COPD
COPD/CHF/Cirrhosis
0
10
$11-$25k
9
20,281
12,641.4688
15,002.5938
26
white
28
24
0.578979
0.385986
2
0
0
no
0.9
0.7
no dnr
9
37
28.296875
129
8
35.40625
188.5625
1.699951
2.299805
4.199219
123
7.189453
111
48
115
1
2
no(M2 and SIP pres)
2
186
1
42.41498
male
0
4
CHF
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
3,282
2,309.2637
2,221.83984
8
white
21.898438
21
0.899902
0.831909
1
0
0
no
0.95
0.9
no dnr
4
68
16
117
40
39
175
2
0.399963
0.699951
138
7.429688
104
7
2,780
0
1
no(M2 and SIP pres)
1
726
0
30.30299
male
0
24
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
52,302
32,196.7656
36,270.9375
35.666657
white
28.597656
51
0.852905
0.80188
1
0
0
no
0.8
0.7
no dnr
24
105
6.399414
112
32
35.19531
164.5
null
1.099854
0.599976
133
7.259766
150
16
680
null
7
adl>=4 (>=5 if sur)
7
725
0
62.66098
male
0
5
CHF
COPD/CHF/Cirrhosis
8
8
under $11k
0
4,819
3,246.1875
2,970.11914
15
white
25
21
0.807983
0.689941
1
1
0
no
0.7
0.7
no dnr
5
86
12.398438
74
24
37
319
3.899902
1
1
133
7.459961
111
14
1,325
0
null
no(M2 and SIP pres)
0.494751
499
1
22.03099
male
0
52
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
111,446
72,256.6875
85,039.8125
25.75
white
24.199219
27
0.909912
0.876953
1
0
0
no
0.7
0.5
no dnr
52
103
5.299805
110
20
36.19531
237.125
2.799805
0.799927
1.799805
142
7.429688
74
34
1.899902
7
7
no(M2 and SIP pres)
7
724
0
62.98398
male
1
32
MOSF w/Malig
ARF/MOSF
1
18
$11-$25k
0
160,668
102,005.562
112,419.062
39.25
white
28.5
31
0.493958
0.375977
15
0
0
yes
0.7
0.7
dnr after sadm
27
69
4.899414
106
32
37.69531
385.6875
1.899902
36.695313
1.399902
149
7.379883
106
12
4,580
0
0
<2 mo. follow-up
0
32
1
54.793
male
0
4
COPD
COPD/CHF/Cirrhosis
2
11
under $11k
0
3,509
2,266.6348
2,573.99805
8
white
16.5
14
0.925903
0.873901
1
0
0
no
null
null
no dnr
4
85
10.298828
104
28
37.5
109.51562
4.299805
0.599976
1.099854
133
7.349609
76
11
null
0
1
no(M2 and SIP pres)
1
721
0
70.97296
female
0
23
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
44,927
26,642.4688
30,721.4062
32.333313
white
29.699219
55
0.539917
0.425964
1
1
0
metastatic
0.2
0.1
no dnr
23
101
5.599609
74
20
37
null
3.799805
0.5
1.099854
137
null
105
15
null
null
2
adl>=4 (>=5 if sur)
2
74
1
53.40698
male
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
16,622
10,085.3672
10,944.2188
24
black
27.699219
32
0.793945
0.725952
1
0
0
no
0.9
0.85
no dnr
10
83
6.699219
104
20
36.29688
null
2.599609
1.099854
1.299805
133
null
129
13
null
1
2
null
2
720
0
57.57199
male
0
3
COPD
COPD/CHF/Cirrhosis
5
10
$25-$50k
0
3,402
2,083.3262
2,233.85938
null
black
14.199219
21
0.931885
0.884888
1
0
0
no
null
null
no dnr
3
107
30.597656
131
28
36.39844
371.375
1.799805
3.199707
1.099854
130
7.449219
146
32
2,284
null
null
null
3.177734
720
0
81.32495
female
1
45
ARF/MOSF w/Sepsis
ARF/MOSF
3
6
under $11k
41
98,873
62,997.375
72,400.25
31
black
23.398438
56
0.603882
0.497986
1
1
0
no
0.65
0.5
dnr after sadm
40
76
10.099609
70
24
36.59375
307.375
2.799805
0.699951
2.099609
147
7.359375
99
54
1,010
null
7
<2 mo. follow-up
7
45
1
50.58197
female
0
16
COPD
COPD/CHF/Cirrhosis
1
9
under $11k
26
43,719
27,188.3125
31,952.6562
32
black
25.199219
28
0.822998
0.711914
1
0
0
no
0.85
0.8
no dnr
16
63
11.199219
114
24
36.59375
null
3.799805
0.899902
1.899902
139
null
119
20
1,650
null
null
null
3.202148
65
1
62.51898
female
0
4
Colon Cancer
Cancer
2
9
under $11k
9
3,170
2,188.7773
2,841.35938
16
hispanic
24.597656
25
0.659912
0.356995
1
1
0
metastatic
0.6
0.2
dnr after sadm
2
69
7.399414
71
32
35.59375
null
4.299805
1.299805
1.5
139
null
88
23
null
7
2
<2 mo. follow-up
2
46
1
80.08197
female
0
11
CHF
COPD/CHF/Cirrhosis
4
4
null
0
16,537
8,672.2656
11,048.1172
25
black
16.199219
19
0.858887
0.766968
1
0
1
no
0.8
0.7
no dnr
11
69
5.399414
114
24
36.09375
null
null
null
0.799927
142
null
113
12
null
2
3
SIP>=30
3
718
0
45.42099
male
0
15
CHF
COPD/CHF/Cirrhosis
2
10
$11-$25k
0
27,278
13,349.4062
17,523.5
18
white
9.099609
20
0.960938
0.932983
1
0
0
no
0.8
0.6
no dnr
15
72
22.199219
121
10
36
218
1.599854
1.399902
2.899902
130
7.389648
393
49
473
0
0
no(M2 and SIP pres)
0
717
0
77.52997
male
1
8
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
0
89,850
57,595.7188
65,648.25
50
white
33
63
0.449951
0.329956
19
0
0
no
0.5
0.3
dnr after sadm
8
115
10.398438
100
20
36.5
288.875
4.599609
1.099854
0.899902
142
7.459961
103
12
null
null
0
<2 mo. follow-up
0
8
1
36.99698
female
1
6
Coma
Coma
2
11
under $11k
0
33,561
22,041.4844
25,715.2188
47
black
41.59375
83
0.294983
0.224976
12
0
0
yes
0.05
0.05
dnr after sadm
2
71
null
70
22
36.29688
155.09375
null
null
1.699951
136
7.429688
116
53
1,390
null
0
<2 mo. follow-up
0
6
1
37.18799
male
1
55
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
158,605
99,295.6875
118,364
38
white
37.796875
61
0.660889
0.562988
2
0
0
no
0.5
0.45
dnr after sadm
54
166
19.5
120
32
36.89844
264
3
0.5
2.299805
142
7.539062
356
40
4,598
null
2
<2 mo. follow-up
2
55
1
72.68994
male
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
under $11k
37
24,423
16,853.5938
19,758.6562
11.5
white
28
44
0.556885
0.444946
1
1
0
no
0.15
0.1
dnr after sadm
1
51
1
124
22
37.79688
125
2.5
2.699707
2.199707
133
7.379883
102
47
2,105
null
6
adl>=4 (>=5 if sur)
6
111
1
81.24799
male
0
55
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
null
37
113,127
72,381.75
87,078.375
41.25
white
22.796875
41
0.453979
0.334961
2
0
0
metastatic
0.8
0.8
no dnr
55
116
16.097656
73
24
38.09375
233.3125
3
0.699951
1.399902
148
7.459961
186
31
1,998
null
0
SIP>=30
0
714
0
52.33398
male
0
5
CHF
COPD/CHF/Cirrhosis
3
11
under $11k
0
4,861
2,851.1953
2,987.98828
8
black
8.599609
12
0.956909
0.924927
1
1
0
no
0.9
0.75
no dnr
5
68
19
122
24
38.39844
225
1.799805
0.899902
1.199951
135
7.419922
98
31
2,630
0
0
no(M2 and SIP pres)
0
391
1
39.33499
male
0
85
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
227,671
142,435.625
157,445.125
36.25
white
27.699219
45
0.817993
0.757935
3
0
0
no
0.6
0.55
no dnr
85
65
13
124
30
37.79688
344
2.899902
0.899902
0.5
148
7.369141
119
6
4,310
null
1
adl>=4 (>=5 if sur)
1
713
0
61.99298
male
1
18
MOSF w/Malig
ARF/MOSF
2
12
under $11k
0
42,526
25,656.2812
29,635.5312
35.333313
white
28.597656
32
0.533936
0.418945
5
1
0
yes
0.15
0.1
dnr after sadm
8
66
8.5
101
40
38.69531
413.3125
2.299805
1.699951
0.899902
142
7.479492
270
24
2,620
null
0
<2 mo. follow-up
0
18
1
56.41898
male
1
50
MOSF w/Malig
ARF/MOSF
2
11
$25-$50k
0
98,742
65,428.8125
86,907.625
23.5
white
23.898438
36
0.711914
0.625
1
0
0
yes
0.5
0.2
dnr after sadm
10
107
8.898438
80
16
36.29688
319
4.299805
0.5
1.799805
137
7.469727
198
23
null
1
1
<2 mo. follow-up
1
50
1
33.63998
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
27,331
17,178.3125
18,940.8281
26
white
31.5
57
0.782959
0.712891
3
0
0
no
0.8
0.75
no dnr
10
113
11.898438
108
26
36.29688
276.1875
3.899902
0.399963
0.799927
138
7.359375
153
18
null
0
0
null
0
712
0
44.08798
male
0
5
CHF
COPD/CHF/Cirrhosis
3
16
under $11k
0
3,698
2,560.4688
2,859.44922
8
black
20.5
47
0.906982
0.842896
1
0
0
no
0.9
0.8
no dnr
5
120
10.099609
112
12
38.89844
154.53125
2.799805
2.099609
1.099854
131
7.399414
108
19
1,562
0
0
no(M2 and SIP pres)
0
492
1
50.95398
female
0
13
MOSF w/Malig
ARF/MOSF
3
10
$25-$50k
0
13,636
9,183.375
12,802.6172
13.5
white
33
37
0.500977
0.383972
1
1
0
yes
1
0.5
dnr before sadm
-1
130
18.199219
147
10
36.19531
182.125
3.099609
0.5
0.799927
133
7.219727
686
22
869
null
4
<2 mo. follow-up
4
33
1
75.78094
male
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
under $11k
0
31,215
20,074.5469
21,948.9375
26
black
29
70
0.625977
0.521973
4
0
0
no
0.75
0.7
no dnr
15
65
34.898438
101
22
39
376.1875
2.899902
1.599854
2
133
7.519531
151
61
1,875
null
0
no(M2 and SIP pres)
0
711
0
61.629
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
9
11,989
7,518.2695
8,195.22656
18
hispanic
13.599609
9
0.906982
0.872925
1
0
0
no
0.95
0.95
no dnr
6
105
4.399414
114
22
37.69531
358
1.599854
9.298828
0.699951
138
7.479492
75
9
1,166
null
0
null
0
710
0
53.37698
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
12,878
7,846.6602
8,019.04688
11.5
white
24.597656
30
0.834961
0.778931
1
0
0
no
0.9
0.9
no dnr
13
107
10.099609
65
9
36
400
2.199707
1.299805
10.298828
142
7.5
156
101
0
6
null
adl>=4 (>=5 if sur)
4.527344
710
0
64.23297
female
0
6
COPD
COPD/CHF/Cirrhosis
4
6
under $11k
0
5,989
4,009.6348
4,146.26953
4
white
14
18
0.894897
0.824951
1
0
0
yes
0.8
0.8
no dnr
6
0
18.5
0
8
33.59375
260
2.199707
10.298828
3.699707
144
7.419922
74
60
3
1
null
no(M2 and SIP pres)
1.166748
710
0
80.07098
female
1
17
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
null
9
46,282
29,802.5625
35,356.0312
42
white
29.796875
47
0.567993
0.45697
2
0
0
no
0.5
0.2
dnr after sadm
8
122
13.599609
113
32
39.79688
165.6875
null
null
1
148
7.549805
114
22
3,525
null
0
<2 mo. follow-up
0
17
1
44.76398
male
0
5
Cirrhosis
COPD/CHF/Cirrhosis
4
12
under $11k
0
6,375
3,729.4258
4,725.96875
19
white
17.597656
27
0.884888
0.80896
1
0
0
no
0.95
0.95
no dnr
5
69
17.597656
146
9
37.89844
153.03125
2.399902
1.799805
1.5
140
7.289062
143
7
2,620
1
0
no(M2 and SIP pres)
0
708
0
57.90298
female
0
6
COPD
COPD/CHF/Cirrhosis
3
5
under $11k
0
6,613
4,251.0508
4,376.21875
16
white
24
37
0.85498
0.760986
1
1
0
no
0.9
0.9
no dnr
6
50
13.099609
101
10
36.39844
150
3
1
2.699707
126
7.459961
177
60
3,116
1
1
no(M2 and SIP pres)
1
708
0
53.96597
female
0
28
COPD
COPD/CHF/Cirrhosis
5
12
>$50k
0
53,536
32,119.7188
36,708.5312
29.25
white
24.199219
49
0.868896
0.782959
1
0
0
no
0.95
0.9
no dnr
28
106
25.097656
76
20
35.89844
null
4.599609
0.799927
1.199951
128
null
124
22
2,865
2
0
SIP>=30
0
84
1
89.58795
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
under $11k
26
12,953
9,127.6875
10,176.9297
7.333332
black
22.199219
18
0.648926
0.549927
1
0
0
no
0.6
0.5
no dnr
15
65
5.099609
62
20
36.19531
null
2.199707
6.399414
1.199951
126
null
209
31
1,300
null
4
no(M2 and SIP pres)
4
705
0
37.689
female
0
7
Cirrhosis
COPD/CHF/Cirrhosis
2
11
under $11k
9
12,902
8,303.4297
9,418.44531
17
white
21.5
37
0.856934
0.763916
1
0
0
no
0.6
0.5
no dnr
7
60
8.099609
70
14
37.89844
null
1.399902
3.099609
0.899902
132
null
104
4
420
0
null
SIP>=30
0.494751
704
0
76.422
male
0
10
COPD
COPD/CHF/Cirrhosis
1
11
under $11k
9
15,849
9,946.5312
10,991.6484
19.5
black
14.398438
24
0.855957
0.761963
1
0
0
no
0.8
0.7
no dnr
10
57
16
127
10
36.19531
152
1.599854
3.299805
1.599854
135
7.419922
287
19
1,185
null
1
no(M2 and SIP pres)
1
548
1
34.69699
male
0
6
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
9
11,810
8,064.6641
9,610.40625
12
white
22.796875
34
0.859985
0.81189
5
0
0
no
0.8
0.7
no dnr
6
103
10.298828
126
16
36.19531
null
3.699707
0.299988
1.099854
130
null
90
12
null
null
1
no(M2 and SIP pres)
1
156
1
49.99899
female
0
15
ARF/MOSF w/Sepsis
ARF/MOSF
4
11
under $11k
0
18,604
11,809.9219
12,744.1562
18.333328
black
22
42
0.872925
0.827881
1
1
0
no
0.7
0.5
no dnr
15
107
6.899414
70
24
36.39844
null
4.299805
1.199951
1.799805
138
null
88
28
null
null
5
no(M2 and SIP pres)
5
702
0
25.31999
female
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
0
13
under $11k
0
21,874
15,546
16,455.1719
10
white
20.898438
29
0.901978
0.866943
10
0
0
no
0.95
0.95
no dnr
7
77
8.199219
52
16
36.19531
null
3.799805
0.599976
1.299805
126
null
86
18
2,885
0
3
no(M2 and SIP pres)
3
699
0
65.112
female
0
68
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
78,561
50,516.25
58,854.6562
20.25
white
23.699219
33
0.816895
0.702881
1
1
0
no
0.1
0.05
no dnr
68
80
17.5
80
28
37.09375
240
2.399902
0.199982
1
136
7.489258
240
16
2,200
0
4
SIP>=30
4
190
1
55.797
female
0
7
CHF
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
5,698
3,965.9062
4,049.62891
6.5
white
14.699219
10
0.92395
0.871948
1
0
0
no
0.6
0.6
no dnr
7
65
13.699219
144
36
36.29688
255.53125
1.799805
0.5
0.799927
133
7.489258
161
20
2,875
0
null
SIP>=30
0.494751
699
0
58.97897
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
0
14,134
8,741.8984
10,157.2422
47
white
24.199219
49
0.730957
0.647949
1
0
0
metastatic
0.05
0
dnr after sadm
3
120
20.796875
133
10
39.29688
147.5
1.799805
0.699951
0.5
145
7.459961
335
14
2,614
null
6
<2 mo. follow-up
6
5
1
80.48499
male
0
7
ARF/MOSF w/Sepsis
ARF/MOSF
2
17
under $11k
0
8,545
5,517.5664
5,961.37891
11
white
22.097656
20
0.779907
0.708984
1
0
0
no
1
1
no dnr
7
106
0.099991
128
30
38.89844
160
3.199707
6.599609
4.799805
136
7.369141
113
99
2,075
1
null
SIP>=30
1.166748
310
1
33.60999
male
1
25
Coma
Coma
4
10
under $11k
44
69,568
35,766.9688
44,304.9062
27
black
27.398438
60
0.660889
0.602905
2
1
0
no
0.05
0.02
dnr after sadm
25
117
12.599609
61
32
38.39844
176
2
0.699951
0.899902
138
7.519531
133
25
4,059
null
1
<2 mo. follow-up
1
25
1
60.375
male
0
16
Cirrhosis
COPD/CHF/Cirrhosis
5
null
null
9
15,397
10,636.5703
11,346.8438
9.333328
white
22.398438
21
0.719971
0.563965
1
0
0
no
0.8
0.5
no dnr
16
62
18
101
26
35.89844
272
2.399902
1.799805
0.799927
121
7.399414
111
57
725
null
null
null
4.429688
696
0
62.67999
male
1
6
Cirrhosis
COPD/CHF/Cirrhosis
2
16
null
0
24,246
15,020.5391
17,635.75
51
white
30.898438
35
0.53894
0.340942
1
0
0
no
0.6
0.55
no dnr
6
162
19
135
8
39
194
5.599609
0.5
1.099854
135
7.169922
146
17
3,730
null
0
<2 mo. follow-up
0
6
1
26.18199
male
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
under $11k
0
55,309
38,386.7188
46,836.7188
19
hispanic
19.796875
57
0.920898
0.891968
3
1
0
no
0.9
0.9
no dnr
40
116
13.699219
65
38
36
340
null
null
2
138
7.369141
64
33
2,300
7
7
SIP>=30
7
207
1
64.20294
male
0
4
COPD
COPD/CHF/Cirrhosis
2
18
under $11k
0
6,455
3,459.8203
4,053.46875
8
white
12.199219
22
0.927979
0.87793
1
0
0
no
0.6
0.5
no dnr
4
65
16.097656
123
8
36.29688
188
null
null
0.599976
128
7.489258
195
11
2,930
1
null
no(M2 and SIP pres)
1.166748
695
0
54.26099
male
1
4
Coma
Coma
3
9
under $11k
100
40,589
25,289.75
30,497.625
43
white
56.5
52
0
0
8
0
0
no
0
0
dnr after sadm
3
63
13.599609
129
14
36.79688
177.125
2.899902
0.399963
1.199951
138
7.299805
147
11
3,565
null
null
<2 mo. follow-up
3.377441
4
1
76.59094
male
0
5
CHF
COPD/CHF/Cirrhosis
5
12
under $11k
9
3,921
2,711.7344
3,071.71875
11
white
18.296875
14
0.784912
0.655884
1
1
0
yes
0.5
0.3
no dnr
5
102
11.099609
94
20
36
360
3.399902
0.899902
1.899902
136
7.479492
100
34
1,625
null
6
adl>=4 (>=5 if sur)
6
694
0
74.49396
female
0
13
MOSF w/Malig
ARF/MOSF
1
null
null
9
18,677
12,616
13,826.8672
16
white
24.5
37
0.507935
0.390991
4
0
0
metastatic
0
0
dnr after sadm
3
57
7.399414
133
8
35.59375
278
3
2.099609
0.299988
137
7.529297
86
18
700
null
null
null
3.882813
163
1
63.01398
male
1
41
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
0
176,364
111,877.75
132,627.125
46.75
white
33.898438
56
0.529907
0.414978
15
0
0
no
0.6
0.5
dnr after sadm
36
75
10.099609
118
16
35.69531
372
3.399902
0.799927
1.799805
136
7.469727
92
19
2,675
null
0
<2 mo. follow-up
0
41
1
58.87997
female
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
under $11k
0
61,942
31,753.5
38,041.0625
24
white
32.898438
46
0.598999
0.490967
9
1
0
no
0.2
0.1
dnr after sadm
6
109
20.199219
107
38
36.29688
208.5625
3.399902
1.5
0.899902
137
7.449219
133
26
2,420
null
1
<2 mo. follow-up
1
14
1
49.98798
male
0
5
Lung Cancer
Cancer
1
12
$25-$50k
0
8,300
5,627.6602
6,072.76953
11
white
9.599609
15
0.848999
0.666992
1
0
0
metastatic
0.9
0.4
no dnr
5
82
14.699219
107
28
38.69531
183.84375
3.299805
3.299805
1
128
7.399414
134
24
4,100
null
null
no(M2 and SIP pres)
2.093262
137
1
72.28699
male
0
13
COPD
COPD/CHF/Cirrhosis
1
10
under $11k
0
25,326
16,010.8594
20,143.9688
11
white
23.199219
29
0.721924
0.566895
11
0
0
no
0.5
0.35
dnr before sadm
-1
101
11.199219
100
20
36.29688
261.875
4
1.399902
0.799927
136
7.40918
94
13
null
2
null
SIP>=30
1.838867
309
1
38.66098
male
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
68,693
43,661.0312
53,243.7812
41.5
white
29.796875
43
0.800903
0.734985
2
0
0
no
0.85
0.85
no dnr
27
114
8.199219
150
50
36
136
2.799805
0.5
1
135
7.379883
248
20
2,505
null
0
SIP>=30
0
689
0
49.202
male
0
34
CHF
COPD/CHF/Cirrhosis
3
null
under $11k
9
30,122
21,783.8438
24,751.8281
13.5
black
35.195313
52
0.66394
0.488953
1
0
0
no
0.9
0.6
dnr after sadm
5
133
8.298828
116
10
35.09375
167.71875
3.299805
1.5
0.799927
140
7.389648
114
19
2,716
null
6
<2 mo. follow-up
6
37
1
55.29099
female
1
18
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
9
56,771
35,733.5
41,528.3438
42
white
25.796875
47
0.751953
0.672974
5
0
0
no
0.3
0.25
dnr after sadm
18
99
4.699219
88
20
36.89844
180
4.399414
0.5
1.399902
131
7.349609
105
16
null
6
6
<2 mo. follow-up
6
18
1
72.047
female
0
6
CHF
COPD/CHF/Cirrhosis
3
12
under $11k
0
4,441
3,018.7148
3,359.75977
8
white
25
33
0.770996
0.634888
1
1
0
no
1
1
no dnr
6
63
49.296875
77
22
36.19531
596
1.799805
0.5
3.699707
137
7.369141
205
53
1,605
1
2
no(M2 and SIP pres)
2
637
1
68.94995
male
0
21
Cirrhosis
COPD/CHF/Cirrhosis
4
12
$11-$25k
37
32,833
21,437.5469
23,775.75
26
white
22.398438
44
0.530884
0.330994
1
1
0
no
0.6
0.3
no dnr
21
128
13.798828
133
6
38
155
3.299805
0.5
1.099854
142
7.319336
106
13
1,492
1
4
<2 mo. follow-up
4
46
1
35.918
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
4
12
$25-$50k
0
18,968
12,872.1094
14,176.5859
17
white
36.398438
62
0.716919
0.630981
1
1
0
no
0.5
0.5
no dnr
14
126
6.599609
107
20
36
null
3.099609
1
1.299805
134
null
193
19
400
0
5
SIP>=30
5
549
1
31.625
male
0
97
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
$25-$50k
0
149,704
96,637.25
106,533.5
45.5
black
21.597656
20
0.888916
0.849976
1
0
0
yes
0.9
0.9
no dnr
97
119
8.298828
50
22
36.5
247.59375
3.599609
0.599976
1.099854
137
7.439453
107
24
null
null
6
adl>=4 (>=5 if sur)
6
687
0
66.81494
female
0
4
COPD
COPD/CHF/Cirrhosis
0
12
under $11k
0
5,201
null
null
8
white
12.798828
9
0.916992
0.859985
1
0
0
no
1
1
no dnr
4
79
7.799805
64
16
36.39844
null
4.599609
0.699951
0.899902
135
null
96
13
900
0
null
no(M2 and SIP pres)
0.494751
685
0
63.89899
female
0
5
Lung Cancer
Cancer
1
9
under $11k
9
4,045
2,675.9766
3,266.0293
12
black
33.398438
23
0.227997
0.025997
1
0
0
metastatic
0.3
0.05
dnr before sadm
-1
53
21.097656
132
12
38.5
108.32812
1.599854
1
1.299805
134
7.439453
296
36
2,755
2
null
<2 mo. follow-up
1.838867
17
1
72.77197
male
0
10
Cirrhosis
COPD/CHF/Cirrhosis
3
9
under $11k
0
12,968
8,341.4062
9,802.61719
10.5
black
20.699219
26
0.69397
0.528931
1
0
0
no
0.8
0.8
no dnr
10
139
1.399902
167
32
32
154
4.299805
0.799927
2.099609
132
7.419922
196
24
3,685
1
1
no(M2 and SIP pres)
1
226
1
59.62997
female
0
3
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
2,429
1,262.1367
1,230.64941
null
black
8.199219
11
0.950928
0.914917
1
1
0
no
null
null
no dnr
3
138
13.798828
129
10
38.39844
66
3
12.298828
0.799927
135
7.469727
147
11
2,385
1
null
SIP>=30
1.166748
684
0
56.60199
male
0
19
COPD
COPD/CHF/Cirrhosis
2
null
under $11k
0
42,496
26,078.9531
29,160.4688
28.333328
white
25.199219
36
0.846924
0.747925
1
0
0
no
0.8
0.7
no dnr
19
99
18.5
100
24
36.89844
137.5
3
1
2.299805
142
7.349609
232
46
1,175
null
1
no(M2 and SIP pres)
1
401
1
69.21594
female
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
0
76,690
48,881.5938
55,026.6875
35
white
17.5
37
0.871948
0.827881
1
1
0
no
0.9
0.9
no dnr
40
115
9.798828
80
12
37.89844
171.09375
2.199707
1.799805
2.799805
137
7.509766
99
40
1,253
null
null
null
2.608398
381
1
79.81696
male
0
114
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
under $11k
0
252,121
162,134.5
197,409.25
58.25
white
29.898438
44
0.590942
0.482971
3
0
0
no
0.35
0.25
dnr after sadm
12
83
7.099609
78
20
36.5
304.75
3.899902
0.599976
1.299805
135
7.459961
395
13
null
null
0
adl>=4 (>=5 if sur)
0
679
0
70.81195
female
0
5
Lung Cancer
Cancer
1
9
under $11k
0
3,972
2,684.6875
3,825.29883
6
white
9.298828
33
0.822998
0.616943
1
0
0
metastatic
0.7
0.2
dnr after sadm
5
139
17.699219
131
35
39.09375
173.3125
2.5
0.399963
1.199951
153
7.419922
280
18
6,520
0
null
adl>=4 (>=5 if sur)
0.494751
245
1
57.88098
male
0
11
CHF
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
8,814
6,131.707
6,662.45703
7
black
18.199219
31
0.895996
0.824951
1
0
0
no
0.5
0.3
dnr after sadm
4
112
3
153
6
37.89844
160
3
0.5
1
150
7.539062
273
10
4,029
0
0
no(M2 and SIP pres)
0
394
1
91.64398
female
0
3
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
2,938
1,826.9522
2,093.66992
null
other
22.398438
25
0.659912
0.483948
1
0
0
yes
1
1
no dnr
3
73
9.099609
80
22
36.19531
512
null
null
1
138
7.449219
124
12
2,050
0
null
no(M2 and SIP pres)
0.494751
241
1
82.06696
male
0
10
CHF
COPD/CHF/Cirrhosis
2
2
under $11k
0
11,305
6,523.6172
7,900.24609
13.5
white
23.296875
38
0.753906
0.610962
1
0
0
no
0.5
0.4
dnr after sadm
4
103
5.599609
74
15
35.69531
182.84375
2.299805
0.5
5.899414
135
7.419922
147
56
2,425
0
0
<2 mo. follow-up
0
28
1
58.198
male
0
9
CHF
COPD/CHF/Cirrhosis
3
13
under $11k
9
9,942
6,615.8359
7,824.79688
10
white
13.5
20
0.917969
0.860962
1
0
0
no
0.9
0.9
no dnr
9
75
53.398438
69
20
36.29688
null
2.5
0.699951
2.399902
132
null
152
75
3,200
null
0
null
0
677
0
67.71796
male
0
3
Lung Cancer
Cancer
2
10
$25-$50k
0
3,124
2,075.2617
2,383.05859
null
white
17.398438
7
0.69397
0.404968
1
0
0
metastatic
0.9
0.6
no dnr
3
71
10.199219
138
51
39.19531
142.5
2.399902
0.899902
1.5
147
7.419922
147
31
4,132
null
null
null
2.623535
158
1
51.04199
female
0
9
MOSF w/Malig
ARF/MOSF
2
null
null
0
24,722
15,592.6641
17,421.125
33
hispanic
23.5
38
0.642944
0.541992
2
0
0
metastatic
null
null
no dnr
9
109
8.099609
72
20
36
null
3.599609
2
2.199707
135
null
84
45
2.47998
null
null
null
3.728027
675
0
54.34399
male
0
5
CHF
COPD/CHF/Cirrhosis
3
16
under $11k
0
3,456
2,491.1348
2,705.87891
12
black
25.796875
24
0.828979
0.720947
1
1
0
no
0.9
0.8
no dnr
5
78
10.699219
120
20
36.89844
null
2.5
3.299805
0.799927
119
null
426
15
1,200
0
0
no(M2 and SIP pres)
0
675
0
70.57898
female
0
35
Coma
Coma
0
12
under $11k
9
100,540
66,278.8125
75,486.0625
23.5
white
20.296875
15
0.60498
0.540894
13
0
0
no
0.8
0.8
no dnr
35
61
15.398438
126
42
36.59375
313.3125
2.099609
0.599976
6.5
144
7.359375
55
65
1,860
null
0
no(M2 and SIP pres)
0
675
0
69.36597
male
1
19
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
$11-$25k
0
64,100
33,446.375
40,356.75
50.333313
white
37.796875
81
0.416992
0.297974
5
0
0
no
0.1
0.1
no dnr
19
77
8.199219
82
24
36.59375
230.53125
3.099609
1.399902
1.199951
139
7.379883
105
14
2,260
null
1
<2 mo. follow-up
1
19
1
74.06696
male
0
34
ARF/MOSF w/Sepsis
ARF/MOSF
4
11
under $11k
0
73,698
46,554.7812
53,819.0938
37.5
white
23.699219
39
0.728882
0.645996
1
1
0
yes
0.5
0.5
dnr after sadm
26
99
15
118
28
38.19531
314.25
4.899414
1.5
0.399963
141
7.359375
95
7
770
null
6
<2 mo. follow-up
6
36
1
74.51599
female
1
15
MOSF w/Malig
ARF/MOSF
2
13
under $11k
26
48,918
30,905.7188
40,094.625
41.666657
white
30.199219
64
0.234985
0.134979
6
0
0
metastatic
0.1
0.001
dnr after sadm
6
64
7.899414
62
22
36.69531
266.625
3.899902
0.699951
0.799927
148
7.399414
152
18
2,950
null
0
<2 mo. follow-up
0
15
1
76.87897
female
0
41
ARF/MOSF w/Sepsis
ARF/MOSF
1
6
under $11k
0
60,870
39,182.9688
51,347.5312
28.75
white
17.597656
13
0.821899
0.761963
5
0
0
no
0.6
0.6
dnr before sadm
-1
66
3
130
32
35.69531
334
1.399902
1
1.5
143
7.489258
80
33
2,026
null
7
<2 mo. follow-up
7
44
1
74.133
male
0
6
COPD
COPD/CHF/Cirrhosis
4
12
under $11k
9
6,695
4,200.4609
4,611.79688
12
white
20.097656
26
0.795898
0.671997
1
0
0
no
0.75
0.65
no dnr
6
106
5.399414
101
30
36.59375
null
2.099609
1.099854
0.899902
139
null
105
11
1,475
6
1
SIP>=30
1
671
0
49.18799
male
0
6
Lung Cancer
Cancer
1
12
under $11k
0
6,588
4,471.5078
5,689.28906
15
white
15.398438
20
0.770996
0.523926
1
0
0
metastatic
0.9
0.7
no dnr
6
69
11.199219
105
24
35.59375
185.6875
3.599609
0.899902
0.899902
133
7.269531
422
13
3,490
0
null
null
0.494751
670
0
72.81598
female
0
11
Lung Cancer
Cancer
1
6
under $11k
0
12,796
8,688.625
12,170.4297
7
white
16.699219
13
0.695923
0.406982
1
0
0
metastatic
0.25
0.05
dnr after sadm
2
130
15.099609
126
12
36.39844
140.71875
4.199219
0.199982
1.599854
133
7.209961
240
33
null
2
0
adl>=4 (>=5 if sur)
0
308
1
89.20996
male
0
5
MOSF w/Malig
ARF/MOSF
1
20
null
0
5,806
4,143.7969
5,598.34766
6
white
24.597656
37
0.598999
0.490967
4
0
0
yes
0.7
0.5
no dnr
5
120
11.798828
124
10
37.19531
142.5
null
null
0.899902
141
7.449219
140
30
1,750
2
0
no(M2 and SIP pres)
0
667
1
35.90399
female
0
7
Colon Cancer
Cancer
1
10
$11-$25k
0
7,600
5,096.7812
6,326.53906
7.5
black
7.5
23
0.934937
0.845947
1
0
0
metastatic
0.5
0.2
no dnr
7
105
11.398438
104
24
36.19531
null
3.599609
0.699951
1.199951
154
7.399414
437
19
1,750
1
0
no(M2 and SIP pres)
0
669
0